A new Swedish study shows that whole genome sequencing can detect clinically relevant genomic abnormalities in acute lymphoblastic leukemia, ALL, and has great potential to be implemented in the diagnostic setting. The study, conducted by researchers within the GMS...
Results from the first 117 children to receive whole genome sequencing through the national GMS Childhood Cancer project show that in 90% of cases, genetic changes of clinical significance were found. The extensive work was carried out by more than 30 researchers and...
In 2022, analyses of 6,700 samples with whole genome sequencing and just over 2,500 samples with whole exome sequencing were performed in clinical routine in Sweden. The majority of the analyses were performed for diagnosing patients with rare diseases. Furthermore,...
Genomic Medicine Sweden launches collaboration with Microsoft in cloud computing, AI and visualisation. The collaboration will enable the vast amount of data generated in precision medicine to be put to the best possible use for patients and research. “It is and...
Genomics data from healthcare can now be shared across Sweden via the National Genomics Platform. This following the signing of agreements between Genomic Medicine Sweden´s (GMS) fourteen partnering regions and universities. Thus far, this is being done within...
Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish Life Science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement...
